| Diana Giordano, | |
|
132 Mansfield Ave, Willimantic, CT 06226-2027 | |
| (860) 456-2261 | |
| Not Available |
| Full Name | Diana Giordano |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 132 Mansfield Ave, Willimantic, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124489851 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Diana Giordano, 132 Mansfield Ave, Willimantic, CT 06226-2027 Ph: (860) 456-2261 | Diana Giordano, 132 Mansfield Ave, Willimantic, CT 06226-2027 Ph: (860) 456-2261 |
News Archive
The National Osteoporosis Foundation today released a position statement providing evidence-based guidance and a national implementation strategy to help children and adolescents achieve optimal bone health, or what is known as "peak bone mass," early in life.
The COVID-19 pandemic has shed new light on the needs for improved disinfection methods, both for individuals and facilities.
"In an aggressive new effort to influence the congressional health care debate, UnitedHealth Group this week e-mailed its 75,000 U.S. employees, urging them to contact their senators and providing two form letters attacking specific legislative proposals," the Minneapolis Star Tribune reports.
Baxter International Inc. and Takeda Pharmaceutical Company Limited today announced that the parties have completed a Development, License and Technology Transfer Agreement. Under the terms of the agreement, Takeda and Baxter will expand upon their previously announced collaboration to bring Vero cell culture-based influenza vaccines to the Japanese market.
Hovione is pleased to announce that its TwinCaps(R) inhaler licensees Daiichi Sankyo Co. Ltd. (Tokyo, Japan) and Biota Holdings Ltd (Victoria, Australia) have both announced successful Phase III trials for CS-8958, a new long-acting neuraminidase inhibitor for treatment of influenza (known as a prodrug of laninamivir).
› Verified 7 days ago
William Bergmann, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1491 Main St, Willimantic, CT 06226 Phone: 860-456-3215 | |
Ms. Jessica M Diaz, MASTER OF ARTS Counselor Medicare: Not Enrolled in Medicare Practice Location: 132 Mansfield Ave, Willimantic, CT 06226 Phone: 860-456-2261 | |
Ning Cruzado, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1310 Main St, Willimantic, CT 06226 Phone: 860-731-5522 Fax: 860-731-5536 | |
Amanda Church, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1310 Main St, Willimantic, CT 06226 Phone: 860-731-5522 Fax: 860-731-5536 | |
Patricia Murphy, Counselor Medicare: Not Enrolled in Medicare Practice Location: 433 Valley St, Willimantic, CT 06226 Phone: 860-456-7200 Fax: 860-731-5536 | |
Taylor Snietka, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1310 Main St, Willimantic, CT 06226 Phone: 860-731-5522 Fax: 860-731-5536 | |
Elizabeth Peterson, LPC Counselor Medicare: Medicare Enrolled Practice Location: 1310 Main St, Willimantic, CT 06226 Phone: 607-315-5228 Fax: 860-731-5536 |